Global Helicobacter Pylori Diagnostics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Helicobacter Pylori Diagnostics Market” is an upcoming report by MarketResearch.biz. The helicobacter pylori diagnostics market segmentation allows for deeper understanding and thought, to decisively assess, analyze, and study. Besides revenues for segments, global, regional, and country-wise, market revenue segmentation will be compiled in a scrupulous manner for clear flow and understanding. The analysis will be conducted using expert opinions and inputs, as well as comprehensive primary and secondary research efforts to establish various aspects of the helicobacter pylori diagnostics market. The global helicobacter pylori diagnostics market report will be segmented on the basis of technology, end-use, and region.
Helicobacter pylori, previously known as Campylobacter pylori, is a gram-negative, helically-shaped, microaerophilic bacterium usually found in the stomach. Its helical shape is thought to have evolved to penetrate the mucoid lining of the stomach and thereby establish infection. This bacteria can act as a causative agent for duodenal ulcers, stomach cancer, infection of the small intestine, gastric ulcers and gastritis.
In 1994, Helicobacter pylori was categorized as a carcinogen by the International Agency for Research on Cancer. It is suggested that the bacteria infects individuals through the fecal-oral route. Some of the primary factors that make helicobacter pylori particularly prevalent in developing nations are poor sanitation, lack of proper water supply, poor personal hygiene levels and denser populations. The rising awareness of helicobacter pylori infections is one of the main factors fueling the global helicobacter pylori diagnostics market. Technological advancements in diagnostic techniques, as well as the need to detect symptoms at an earlier stage, are factors that will positively contribute to the growth of the global helicobacter pylori diagnostics market.
In terms of technology, the market is segmented into – immunoassays, POC, and molecular diagnostics. The immunoassay segment accounted for the largest revenue share in 2018 and is projected to continue to do so over the next ten years. Although Point of Care tests is commonly used, molecular diagnostics accounted for the second-largest market share in 2018.
With respect to end-use, the market is categorized into – hospitals, diagnostic laboratories, and clinics. The hospital segment accounted for the largest revenue share in 2018 owing to the accessibility of doctors, ease of disease presentation, and the increasing prevalence of diseases such as gastritis, stomach cancer, gastric ulcers, duodenal ulcers, etc.
The diagnostics laboratory segment is expected to index the fastest CAGR over the foreseeable future due to specialized infection detection methods along with the rising awareness of infectious diseases.
The market in North America accounted for the largest revenue share in 2018 due to a better economy and the development of the healthcare sector. However, the Asia Pacific market is projected to index the fastest CAGR over the next tens years due to the increasing prevalence of helicobacter pylori infections and booming populations rates.
Global Helicobacter Pylori Diagnostics Market Segmentation:
Global Helicobacter Pylori Diagnostics Market segmentation, by Technology:
- Molecular Diagnostics
Global Helicobacter Pylori Diagnostics Market Segmentation, by End-Use:
- Diagnostics Laboratories
Global Helicobacter Pylori Diagnostics Market Segmentation, by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Thermo Fisher Scientific
- Quest Diagnostics
- Meridian Bioscience
- Bio-Rad Laboratories
- Alpha Laboratories
- Hoffmann-La Roche
- Coris BioConcept
- CerTest Biotec
- Epitope Diagnostics
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!